Source: Kapitales Research

Highlights:

• Weebit Nano rallied after completing a strongly supported $15 million Share Purchase Plan
• Smart Parking extended gains as investors continued rotating into high-growth technology names
• 4DMedical climbed more than 10% even as the ASX healthcare sector fell 1.47% during the session

ASX growth and technology-linked stocks attracted strong investor attention on Thursday, with Weebit Nano, Smart Parking, and 4DMedical posting double-digit gains despite broader market weakness across several sectors. The rally reflected renewed investor appetite for high-growth innovation companies, particularly those linked to semiconductors, artificial intelligence, and advanced healthcare technologies.

Stocks mentioned:

• Weebit Nano Ltd (ASX: WBT) surged 20.4% to $6.02
• Smart Parking Limited (ASX: SPZ) gained 11.0% to $0.905
• 4DMedical Limited (ASX: 4DX) climbed 10.6% to $3.74

Weebit Nano jumps after successful capital raise

Weebit Nano shares surged 20.4% to $6.02 after the semiconductor memory technology company announced it had raised approximately $15 million through a strongly supported Share Purchase Plan (SPP). The SPP lifted the company’s total recent capital raising to approximately $102 million, including an earlier $87 million placement to institutional and Israeli investors.

The company said the funds would be used to accelerate the scale-up and commercialisation of its ReRAM technology, expand AI-related offerings, and support broader growth initiatives. Investor sentiment was also boosted by comments from Weebit Nano CEO Coby Hanoch, who highlighted the company’s progress in automotive-grade ReRAM qualification, licensing agreements, and commercial product development.

Smart Parking extends technology-driven momentum

Smart Parking climbed 11% to $0.905 as investors continued favouring small-cap technology and smart infrastructure stocks. The company has remained a strong momentum name on the ASX due to its exposure to smart-city infrastructure, parking technology systems, and scalable recurring revenue opportunities. Market participants appeared to rotate into higher-growth technology names amid improving risk appetite for speculative sectors.

4DMedical rises despite healthcare sector weakness

Meanwhile, 4DMedical advanced 10.6% to $3.74 even as the broader ASX healthcare sector declined 1.47% during the trading session. The move highlighted strong investor confidence in the company’s respiratory imaging and diagnostics technology despite weakness across the wider healthcare space. The stock has increasingly drawn investor attention due to its advanced lung imaging platform and exposure to long-term healthcare innovation trends.

Investors continue chasing growth opportunities

The strong gains across WBT, SPZ, and 4DX suggest investors remain willing to back innovation-led ASX companies with scalable technology platforms and long-term commercial potential. Market participants are expected to closely watch upcoming announcements, commercial milestones, and broader market sentiment to determine whether momentum in high-growth ASX technology and healthcare stocks can continue.

Note- All data presented is based on information available at the time of writing.

Disclaimer for Kapitales Research

The materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au